BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Percutaneous Coronary Intervention Biotronik Orsiro DES
Sponsor
Biotronik AG